Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. - Wikidata - wikimedia - TriplyDB

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.

http://www.wikidata.org/entity/Q40498619

about

Accelerating the development of a group A Streptococcus vaccine: an urgent public health need Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus Coiled-Coil Irregularities and Instabilities in Group A Streptococcus M1 Are Required for Virulence Anti-Group A Streptococcal Vaccine Epitope: STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULES Structure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A Streptococcus Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013.Streptococcal pharyngitis in schoolchildren in Bamako, Mali.The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape.Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence.Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever.Factors associated with Group A Streptococcus emm type diversification in a large urban setting in Brazil: a cross-sectional study.Preferences for health outcomes associated with Group A Streptococcal disease and vaccination.Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003 Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin.Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever.Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature.Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates.Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway.Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.A vaccine against Streptococcus pyogenes: the potential to prevent rheumatic fever and rheumatic heart disease.Disease manifestations and pathogenic mechanisms of Group A Streptococcus.StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice.Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.Antimicrobial susceptibility patterns, emm type distribution and genetic diversity of Streptococcus pyogenes recovered in Brazil Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.Genes, autoimmunity and pathogenesis of rheumatic heart disease.Application of the C3-binding motif of streptococcal pyrogenic exotoxin B to protect mice from invasive group a streptococcal infection Emergence of Streptococcus pyogenes emm102 causing toxic shock syndrome in Southern Taiwan during 2005-2012.Protective immunogenicity of group A streptococcal M-related proteins.Rheumatic fever and its management.Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level Clinical and molecular characteristics of invasive and noninvasive skin and soft tissue infections caused by group A Streptococcus StreptInCor: a model of anti-Streptococcus pyogenes vaccine reviewed.

P2860

Q26739210-45761307-8792-482E-9E9D-3A814A7AED71 Q27009175-BF715213-910E-4563-B1B7-DB41FA0BF507 Q27650002-3144822F-5537-470C-A6E7-073854BA7D77 Q27666345-B25067F5-295E-4BED-B443-793449C0F732 Q27679389-05504BE3-B6BC-4C8D-BA0C-426D41BC4934 Q28729759-AA0C0781-DACE-444C-B23C-64502F28F72B Q30202103-D1A4D985-03CA-43D0-A06F-9915ECD96D69 Q30301331-A5357B24-ED59-4374-B645-D6CFAA3E7E4A Q30432965-FA6F5895-2EFF-43B3-80D0-3D1496FEC2E4 Q33267269-754A5506-0A32-42D7-9810-B3C411BB8396 Q33507907-240B978F-0D7C-43CC-9941-07E2AE07E43E Q33627302-9BEDB39E-411F-4A9E-8D19-DC3D60F4B650 Q33744547-381017B0-F3D4-4A1D-B58E-7AD17CDFC061 Q33763940-5FF75C7D-0D31-4540-868F-4AF1C86839B5 Q33877781-86DED076-9DAF-4EA2-A373-1935F94FDB55 Q33899693-02D13D53-089C-4331-BE9A-A8B1D7F8F2DE Q33910815-4CDE7EDF-58FC-40D5-844F-02A23F5E79EB Q34005434-C6BA29CB-5993-4C7E-A7E1-ABD215B5E2BF Q34022219-422708C3-75F7-4C9D-8DCB-7558FBD85966 Q34036156-08659474-17D1-47F0-85C7-99E756473B88 Q34041403-8A479ABC-8795-4717-BD55-CBB8DC1AA23B Q34112608-AF5F3DBB-50E1-4ACB-A877-44F96B1DCE4F Q34131103-796E056B-9787-4EF9-8FE6-0C2E90AA319C Q34131142-067F523B-433F-42F8-BEB4-81CD848E9F53 Q34151601-630F2AA6-DA99-4AE3-8AC7-859607D5EE75 Q34250054-6C66A730-91AC-4250-A53B-338F7972F7DB Q34324694-A594052C-1C41-44E5-8100-BA83947C235B Q34413457-B22E61EE-8466-43EC-A713-87D2E76ABDD4 Q34674395-678973D4-A408-4DDE-8D10-A0BFA1AB94F6 Q34971503-B928BFA8-41E9-421B-81E5-8BC6A8F2F46A Q34975899-327AA92D-D80F-4590-9025-28E5858DC15C Q34988307-A0CB2530-7CFD-4A51-B215-C9DE90D6CA94 Q35015039-A4D6F61B-803D-4067-A43A-E31411D62C3C Q35023478-3E6FB9AD-FE96-4EC5-B70D-D735A238E739 Q35069734-B829CB5E-34F9-46C0-9F87-19A9C2F05670 Q35122760-4B38039C-A484-4F4E-9F5F-2ACE003624E7 Q35185714-80507D26-9CB3-4D3C-A3D1-A658869B11FB Q35220818-02858452-4BD6-4465-AB8A-82006B8933C5 Q35273594-D0CE00D0-172B-4449-B99C-9F01DEFDAE68 Q35309203-6255655C-7693-4202-ADE3-50DD28B0A76B

P2860

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.

http://www.wikidata.org/entity/Q40498619

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Safety and immunogenicity of 2 ...... e in healthy adult volunteers.

@en

type

label

Safety and immunogenicity of 2 ...... e in healthy adult volunteers.

@en

prefLabel

Safety and immunogenicity of 2 ...... e in healthy adult volunteers.

@en

P1433

Q40498619-A189A6DF-BEAA-4387-927D-62FFB833B527

P1476

Q40498619-8C593153-AAAD-4C94-9C69-26AE1E22C154

P2093

Q40498619-3A6C7F90-387F-4BA2-94A7-39CF5EA81A0F

Q40498619-4403ADA7-102B-47D7-9D31-F4A2D5AF3E4E

Q40498619-4DC1932E-B75E-4132-B4C8-9509BEA10971

Q40498619-50B92A04-21EA-4E7E-ACC3-1EDFE5B4FF95

Q40498619-721ACF30-7EDF-40CC-B843-AE04880ABDC1

Q40498619-7CC60C20-1851-4EA1-A3D8-4F34A20C981A

Q40498619-DB5D7EB1-3E15-48B5-8DDA-E0CC9D03E642

Q40498619-E111641A-9615-4534-B4EE-B9F59C014B14

Q40498619-FCD02D3A-7094-4503-BB48-B4A37F02A0AB

P2860

Q40498619-0FB2A68C-99A0-4CF4-BDC4-2EE104B3B5CC

Q40498619-1564D5E8-BE4F-42E7-AE19-ECB131862290

Q40498619-2189A222-924F-41FB-97C8-23B7FDAD9CD0

Q40498619-36CCDA24-4005-447A-BDBB-DD9284F8A2FA

Q40498619-3D92453A-45A4-4C28-8057-FE7CFFF39A90

Q40498619-3F2EFB2D-CD63-4C55-8F67-0438E5714015

Q40498619-4644EF27-619E-4FC0-AECC-B0EA68B709EB

Q40498619-4B2C7975-3222-49AC-B838-4B05530CA574

Q40498619-5E51EAA8-54A6-48C1-B41F-0BB582B6EDE2

Q40498619-67FE00B4-4DAC-4B8E-971B-B9207FB9277E

P304

Q40498619-80EA8E28-A136-4AFB-8161-95065F74B112

P31

Q40498619-EBC5832C-8791-4ABB-92FC-8BE74CED7203

P356

Q40498619-0B10218E-363B-44AC-9AB2-454380910136

P407

Q40498619-A7B1BC19-674E-4006-ABE3-76424129E3E3

P433

Q40498619-FFA384FE-B812-49C3-A09B-BFA52B9489AB

P478

Q40498619-1E476B12-0C28-4CE8-8801-FC688D4054D0

P50

Q40498619-081121AA-6FFF-4690-834C-696FA19C72CB

Q40498619-0D414F5B-2F20-4C31-88A7-7514574EAD08

Q40498619-0F145729-0774-49D0-A64E-71314645C831

Q40498619-E7E0BBD4-BC02-4E84-A2B9-E1B6E02EB813

Q40498619-F270FA35-F44A-4A30-BAC7-BD9C6B60E09D

P577

Q40498619-54F1A469-75EC-44A8-86DF-97FD8D41E38E

P5875

Q40498619-99105708-E9A0-4842-8234-E85129A8C54C

P698

Q40498619-D8BC3B88-69FA-4A4F-80E9-8A2E83949572

P356

P1433

Clinical Infectious Diseases

P1476

Safety and immunogenicity of 2 ...... e in healthy adult volunteers.

@en

P2093

Andrew Warren

http://www.w3.org/2001/XMLSchema#string

Bruce Smith

http://www.w3.org/2001/XMLSchema#string

Darlene M Baxendale

http://www.w3.org/2001/XMLSchema#string

Geoffrey P Sharratt

http://www.w3.org/2001/XMLSchema#string

Janine Linden

http://www.w3.org/2001/XMLSchema#string

Louis F Fries

http://www.w3.org/2001/XMLSchema#string

Mark A Reddish

http://www.w3.org/2001/XMLSchema#string

Mary C Hu

http://www.w3.org/2001/XMLSchema#string

Steven D Stroop

http://www.w3.org/2001/XMLSchema#string

P2860

Active bacterial core surveillance of the emerging infections program network.

New protective antigen of group A streptococci.

Persistence of type-specific antibodies in man following infection with group A streptococci

STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS

Immunogenicity of a 26-valent group A streptococcal vaccine.

M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.

Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes.

Recall of type specific antibodies in man by injections of streptococcal cell walls.

The reemergence of serious group A streptococcal infections and acute rheumatic fever.

Resurgence of acute rheumatic fever in the intermountain area of the United States.

P304

1114-1122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/444458

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Joanne M. Langley

Shelly A McNeil

Scott A Halperin

P577

2005-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7598647

http://www.w3.org/2001/XMLSchema#string

P698

16163629

http://www.w3.org/2001/XMLSchema#string